Como Citar
Referências
Boekhout T, Theelen B, Diaz M. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiol 2001; 147:891–907
Byrnes EJ, LI W, Lewit Y. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010, 6:e1000850.
Carriconde F, Gilgado F, Arthur I, Ellis D, Malik R, van de Wiele N, et al. Clonality and recombination in the Australian Cryptococcus gattii VGII population—an emerging outbreak in Australia. PLoS One 201, 6:e16936.
Datta K, Bartlett KH, Marr KA Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche. Interdiscip Perspect Infect Dis 2009: 17258–17263.
Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 2005, 437:1360–1364.
Kidd SE, Hagen F, Tscharke RL. A rare genotype of Cryptococcus gattii caused the cryptococcosis Bol Inst Adolfo Lutz. 2014; 24(1):36-39 • 39 outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101:17258– 63.
Kwon-Chung, K. J. and Varma, A., Do major species concepts support one, two or more species within Cryptococcus neoformans?. FEMS Yeast Research 2006, 6:574–587.
Lockhart SR. Epidemiological cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis 2012, 73:144–148.
Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009, 12:1–14.
Meyer W, Marszewska K, Amirmostofina M, Igreja RP, Hardtke C, Methling K, et al. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by PCR-fingerprinting and RAPD. A pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 1999, 20:1790–9.
Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E and the IberoAmerican Cryptococcal Study Group. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003, 9:189–95.
Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:291–322.
Trilles L, Meyer W, Wanke B, Guarro J, Lazéra M. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol 2012, 50:328–32